Energy exchange between discrete breathers in graphane in thermal equilibrium
Publication date: Available online 27 February 2019Source: Physics Letters AAuthor(s): K.A. Krylova, J.A. Baimova, R.T. Murzaev, R.R. MulyukovAbstractGraphane is a fully hydrogenated graphene which is practically interesting for application in electronics, hydrogen storage and transportation, in nanoscale devices. As it was previously shown, the energy of a discrete breather (nonlinear localised mode) in graphane close to the value of the energy barrier at which the dehydrogenation of graphene occurs. In the present work, molecular dynamics simulation is used to investigate the possibility of energy exchange between discrete breathers in graphane in thermal equilibrium at 400 K and 600 K. In thermally equilibrated graphane, hydrogen atoms are spontaneously excited and can be considered as discrete breathers. Comparison of the kinetic energy per atom as the function of time for the selected hydrogen atoms with their displacements along the z axis showed that there is an energy exchange between the discrete breathers at evaluated temperatures. Hydrogen atom, transmitting its energy to the neighboring atom no longer exists as discrete breather. At high temperatures (600 K) the energy exchange between closely located discrete breathers also take place but strong thermo-oscillations of atoms at high temperatures (above 400 K) considerably affect the process.
CONCLUSIONS: The concept of soldier-centered care often emerges in discussions about optimal physical performance and medical readiness for soldiers. Although soldier-centered care and patient-centered care have similar conceptual underpinning, it is important to clarify the unique physical and medical requirements for soldiers that differentiate soldier-centered care from patient-centered care. Implementing the defining attributes of soldier-centered care in the U.S. Army primary care setting may improve the quality of care and health outcomes for soldiers. When defining performance metrics for primary care models of care...
Authors: Waller SG Abstract Three important but neglected principles of evaluation of global health engagement missions are stakeholder engagement, impact, and relative value. Implementing better M&E programs could be carried out in this fiscal year, without new appropriations or manpower. The result would be cost savings and improved security cooperation. PMID: 31942621 [PubMed - as supplied by publisher]
Publication date: Available online 18 January 2020Source: Clinica Chimica ActaAuthor(s): Guodong Zhao, Yong Ma, Hui Li, Shiming Li, Yun Zhu, Xiaoyu Liu, Shangmin Xiong, Yi Liu, Jin Miao, Sujuan Fei, Minxue Zheng, Xiangwei ZhaoAbstractBackgroundMethylated SFRP2 was previously reported as a non-invasive biomarker for colorectal cancer (CRC) detection with a relatively low sensitivity for early stage CRC. The purpose of this study was to evaluate the performance of a new plasma based CRC screening assay, SpecColon test, which tested methylated SFRP2 and SDC2 simultaneously in a single qPCR reaction, in detecting CRC and advan...
CONCLUSIONS: MHR may be a significant and independent predictor of poor functional outcome in patients with AIS. PMID: 31941849 [PubMed - as supplied by publisher]
Authors: Ieda N, Assadullah, Minabe S, Ikegami K, Watanabe Y, Sugimoto Y, Sugimoto A, Kawai N, Ishii H, Inoue N, Uenoyama Y, Tsukamura H Abstract Accumulating evidence suggests that kisspeptin neurons in the arcuate nucleus (ARC), which coexpress neurokinin B and dynorphin, are involved in gonadotropin-releasing hormone (GnRH)/luteinizing hormone (LH) pulse generation, while the anteroventral periventricular nucleus (AVPV) kisspeptin neurons are responsible for GnRH/LH surge generation. The present study aims to examine whether GnRH(1-5), a GnRH metabolite, regulates LH release via kisspeptin neurons. GnRH(1-5) was...
In conclusion, caffeine decreased oxidative stress and adipogenesis in GO orbital fibroblasts in vitro. These findings may contribute to the development of new types of caffeine-containing pharmacological agents for use in the management of GO. PMID: 31941844 [PubMed - as supplied by publisher]